Research On Financial Risk Early Warning Of H Pharmaceutical Company Based On Efficacy Coefficient Method

With the rapid development of the national economy and the increasingly complex economic situation at home and abroad,financial risk has gradually become a problem that cannot be ignored and needs to be paid attention to in the process of enterprise development and operation.As an important part of the national economy,the pharmaceutical industry is deeply influenced by the changes of national policies,market competition and other factors,coupled with the three-high characteristics of "high investment,high risk and high profit",and its financial risk has always been the focus of extensive attention of the government and the public.Under this background,this thesis selects H Pharmaceutical Company,which is relatively mature and influential in China,to analyze its financial risk,and makes an in-depth study on the construction of its financial risk early warning model.The research idea of this thesis is to start with the analysis of the theoretical status quo of financial risk early warning research by scholars at home and abroad,and summarize the financial risk theory and financial risk early warning theory by synthesizing various new theoretical research results.Then,combined with the characteristics of the pharmaceutical industry,the existing financial situation and early warning sources of the enterprise are identified and analyzed,and the necessity of building a financial risk early warning model for the company is put forward.The next step is to explore the establishment of a financial risk early warning model system suitable for this enterprise.The process is as follows:Firstly,14 financial indicators are selected from four aspects by correlation coefficient analysis on SPSS software for data preprocessing;Secondly,choose the objective weighting method-entropy method to calculate the corresponding index weight;Then,guided by the improved theory of efficacy coefficient method,the financial data of the company from2016 to 2020 are brought into the early warning model,and the comprehensive evaluation value of financial risk in the last five years is obtained and relevant analysis is made.Finally,according to the early warning results,the problems existing in the development process of H Pharmaceutical Company are summarized,and specific countermeasures are put forward from five aspects: strengthening cost control,scientifically planning and financing,strengthening accounts receivable management,improving investment and innovation,and perfecting financial risk early warning system,so as to promote the sustainable development of the enterprise.To a certain extent,the research of this thesis can help H Company to reduce the impact of financial risks in its future operation,maintain its health and long-term development,and also provide some reference and thinking for other pharmaceutical companies in China in financial risk early warning.